表紙
市場調查報告書

單株抗體的全球市場 - 考察與預測,COVID-19的潛在影響:2020年∼2024年

Global Monoclonal Antibodies Market (By Source, Application, End-Users & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

出版商 Koncept Analytics 商品編碼 950619
出版日期 內容資訊 英文 128 Pages
訂單完成後即時交付
價格
單株抗體的全球市場 - 考察與預測,COVID-19的潛在影響:2020年∼2024年 Global Monoclonal Antibodies Market (By Source, Application, End-Users & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)
出版日期: 2020年07月21日內容資訊: 英文 128 Pages
簡介

全球單株抗體市場,2024年達到1,617億美元,預計2020年∼2024年以7.21%的年複合成長率成長。促進市場成長的要素,是新癌症病例的發生率增加,生技藥品的銷售額增加,老年人口擴大,醫藥品R&D費用增加,糖尿病的患病數上升,醫療費劇增等。

本報告提供全球單株抗體市場相關調查分析,市場規模,市場動態,競爭情形,主要企業等系統性資訊。

目錄

第1章 概要

  • 簡介
  • 單株抗體的種類
  • 單株抗體的來源
  • 單株抗體的優點和缺點
  • 單株抗體的應用
  • 單株抗體的製造流程

第2章 COVID-19的影響

  • 由於COVID-19的死亡數增加
  • 政府的醫療支出增加
  • 血漿療法的採用
  • COVID-19單株抗體候補藥臨床實驗

第3章 全球市場分析

  • 全球單株抗體市場:各金額
  • 全球單株抗體市場預測:各金額
  • 全球單株抗體市場金額:各來源
  • 全球單株抗體市場金額:各適應症
  • 全球單株抗體市場金額:各終端用戶
  • 全球單株抗體的生產量和需求量
  • 全球單株抗體市場金額:各地區

第4章 各地區的市場分析

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第5章 市場動態

  • 成長促進因素
  • 主要趨勢與開發
  • 課題

第6章 競爭情形

  • 全球市場
    • 主要企業:收益比較
    • 主要企業:R&D費比較
    • 主要企業:市值比較

第7章 企業簡介

  • Johnson & Johnson
  • Novartis AG
  • Merck and Co.
  • AbbVie Inc.
  • Bristol-Myers Squibb
  • Amgen AG
目錄

The global monoclonal antibodies market is expected to reach US$161.7 billion in 2024, increasing at a CAGR of 7.21%, for the duration of 2020-2024. The factors such as, increasing incidences of new cancer cases, escalating sales of biologics, growth in geriatric population, increasing pharmaceutical R&D spending, rise in prevalence of diabetes and upsurge in healthcare expenditure would drive the growth of the market. However, the market growth would be challenged by high cost involved in the development of the therapeutic monoclonal antibodies, threats associated with drugs counterfeiting and legal regulations. A few notable trends include accelerating growth rates of infectious diseases, growth in the pharmaceutical & biotechnology M&A, development of new monoclonal antibodies and emergence of stereo-specific monoclonal antibodies.

The global monoclonal antibodies market is very lucrative as there is wide scope for its application for various indications. The rising prevalence of cancer is leading to the demand for humanized monoclonal antibodies as such class of drugs can target cancer cell at rapid speed as well as reduce their multiplication. In addition, monoclonal antibodies have found application in research and development of various novel drugs as well as therapies, which is providing a great opportunity for its market growth across the world.

The fastest growing regional market is North America due to the presence of biopharmaceutical key players and the well-established healthcare infrastructure. It is followed by Europe and Asia Pacific, which also hold considerable share in the global market, owing to the increased application of monoclonal antibodies. Further, the rising number of coronavirus cases is augmenting the need for precise therapeutic options, which is leading to the development of mono-specific and thereby would help the monoclonal antibodies market to grow considerably in coming year.

Scope of the report:

  • The report provides a comprehensive analysis of the global monoclonal antibodies market.
  • The major regional markets (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) have been analyzed.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Johnson & Johnson, Novartis AG, Merck & Co., AbbVie Inc., Bristol-Myer Squibb and Amgen AG) are also presented in detail.

Key Target Audience:

  • Monoclonal Antibodies Manufacturers
  • Pharmaceuticals and Biopharmaceutical Firms
  • End Users (Hospitals and Research Institutes)
  • Investment Banks
  • Healthcare and Medical Consultants.
  • Government Bodies & Regulating Authorities

Table of Contents

1. Overview

  • 1.1 Introduction
  • 1.2 Types of Monoclonal Antibodies
  • 1.3 Source of Monoclonal Antibodies
  • 1.4 Advantages and Disadvantages of Monoclonal Antibodies
  • 1.5 Monoclonal Antibodies Applications
  • 1.6 Monoclonal Antibody Production Process

2. Impact of COVID-19

  • 2.1 Rise in COVID-19 Death Toll
  • 2.2 Growth in Government Spending on Healthcare
  • 2.3 Adoption of Plasma Therapy
  • 2.4 COVID-19 Monoclonal Antibody Candidate Drugs in Trial

3. Global Market Analysis

  • 3.1 Global Monoclonal Antibodies Market by Value
  • 3.2 Global Monoclonal Antibodies Market Forecast by Value
  • 3.3 Global Monoclonal Antibodies Market Value by Source
    • 3.3.1 Global Humanized Monoclonal Antibodies Market by Value
    • 3.3.2 Global Humanized Monoclonal Antibodies Market Forecast by Value
    • 3.3.3 Global Human Monoclonal Antibodies Market by Value
    • 3.3.4 Global Human Monoclonal Antibodies Market Forecast by Value
    • 3.3.5 Global Chimeric Monoclonal Antibodies Market by Value
    • 3.3.6 Global Chimeric Monoclonal Antibodies Market Forecast by Value
    • 3.3.7 Global Murine Monoclonal Antibodies Market by Value
    • 3.3.8 Global Murine Monoclonal Antibodies Market Forecast by Value
  • 3.4 Global Monoclonal Antibodies Market Value by Indication
    • 3.4.1 Global Cancer Monoclonal Antibodies Market by Value
    • 3.4.2 Global Cancer Monoclonal Antibodies Market Forecast by Value
    • 3.4.3 Global Autoimmune Diseases Monoclonal Antibodies Market by Value
    • 3.4.4 Global Autoimmune Diseases Monoclonal Antibodies Market Forecast by Value
    • 3.4.5 Global Infectious Diseases Monoclonal Antibodies Market by Value
    • 3.4.6 Global Infectious Diseases Monoclonal Antibodies Market Forecast by Value
  • 3.5 Global Monoclonal Antibodies Market Value by End-Users
    • 3.5.1 Global Hospital Monoclonal Antibodies Market by Value
    • 3.5.2 Global Hospital Monoclonal Antibodies Market Forecast by Value
    • 3.5.3 Global Research Institutes Monoclonal Antibodies Market by Value
    • 3.5.4 Global Research Institutes Monoclonal Antibodies Market Forecast by Value
  • 3.6 Global Monoclonal Antibodies Capacity and Demand Volume
  • 3.7 Global Monoclonal Antibodies Market Value by Region

4. Regional Market Analysis

  • 4.1 North America
    • 4.1.1 North America Monoclonal Antibodies Market by Value
    • 4.1.2 North America Monoclonal Antibodies Market Forecast by Value
    • 4.1.3 North America Monoclonal Antibodies Market by Region
    • 4.1.4 The U.S. Monoclonal Antibodies Market by Value
    • 4.1.5 The U.S. Monoclonal Antibodies Market Forecast by Value
    • 4.1.6 The U.S. Monoclonal Antibodies Market by Application
    • 4.1.7 The U.S. Cancer Monoclonal Antibodies Market by Value
    • 4.1.8 The U.S. Cancer Monoclonal Antibodies Market Forecast by Value
    • 4.1.9 The U.S. Autoimmune Diseases Monoclonal Antibodies Market by Value
    • 4.1.10 The U.S. Autoimmune Diseases Monoclonal Antibodies Market Forecast by Value
    • 4.1.11 The U.S. Infectious Diseases Monoclonal Antibodies Market by Value
    • 4.1.12 The U.S. Infectious Diseases Monoclonal Antibodies Market Forecast by Value
  • 4.2 Europe
    • 4.2.1 Europe Monoclonal Antibodies Market by Value
    • 4.2.2 Europe Monoclonal Antibodies Market Forecast by Value
  • 4.3 Asia Pacific
    • 4.3.1 Asia Pacific Monoclonal Antibodies Market by Value
    • 4.3.2 Asia Pacific Monoclonal Antibodies Market Forecast by Value
  • 4.4 Latin America
    • 4.4.1 Latin America Monoclonal Antibodies Market by Value
    • 4.4.2 Latin America Monoclonal Antibodies Market Forecast by Value
  • 4.4 Middle East & Africa
    • 4.5.1 Middle East & Africa Monoclonal Antibodies Market by Value
    • 4.5.2 Middle East & Monoclonal Antibodies Market Forecast by Value

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Rising Incidences of New Cancer Cases
    • 5.1.2 Escalating Sales of Biologics
    • 5.1.3 Growth in Geriatric Population
    • 5.1.4 Increasing Pharmaceutical R&D Spending
    • 5.1.5 Rise in Prevalence of Diabetes
    • 5.1.6 Upsurge in Healthcare Expenditures
  • 5.2 Key Trends and Developments
    • 5.2.1 Accelerating Growth Rates of Infectious Diseases
    • 5.2.2 Growth in Pharmaceutical and Biotech Merger & Acquisition
    • 5.2.3 Development of New Monoclonal Antibodies
    • 5.2.4 Emergence of Stereo-specific Monoclonal Antibodies
  • 5.3 Challenges
    • 5.3.1 High Cost Involved
    • 5.3.2 Threats Associated with Drugs Counterfeiting
    • 5.3.3 Legal Regulations
  • 6.Competitive Landscape
  • 6.1 Global Market
    • 6.1.1 Key Players - Revenue Comparison
    • 6.1.2 Key Players - R&D Expenditure Comparison
    • 6.1.3 Key Players - Market Capitalization Comparison

7. Company Profiles

  • 7.1 Johnson & Johnson
    • 7.1.1 Business Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
  • 7.2 Novartis AG
    • 7.2.1 Business Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
  • 7.3 Merck and Co.
    • 7.3.1 Business Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 AbbVie Inc.
    • 7.4.1 Business Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies
  • 7.5 Bristol-Myers Squibb
    • 7.5.1 Business Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Business Strategies
  • 7.6 Amgen AG
    • 7.6.1 Business Overview
    • 7.6.2 Financial Overview
    • 7.6.3 Business Strategies

List of Figures

  • Types of Monoclonal Antibodies
  • Source of Monoclonal Antibodies
  • Monoclonal Antibodies Applications
  • Monoclonal Antibody Production Process
  • Global Government Share on Health Spending (2019-2024)
  • Global Plasma Therapy Market Forecast (2019-2024)
  • Global Monoclonal Antibodies Market by Value (2015-2019)
  • Global Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Global Monoclonal Antibodies Market Value by Source (2019)
  • Global Humanized Monoclonal Antibodies Market by Value (2015-2019)
  • Global Humanized Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Global Human Monoclonal Antibodies Market by Value (2015-2019)
  • Global Human Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Global Chimeric Monoclonal Antibodies Market by Value (2015-2019)
  • Global Chimeric Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Global Murine Monoclonal Antibodies Market by Value (2015-2019)
  • Global Murine Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Global Monoclonal Antibodies Market Value by Indication (2019)
  • Global Cancer Monoclonal Antibodies Market by Value (2015-2019)
  • Global Cancer Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Global Autoimmune Diseases Monoclonal Antibodies Market by Value (2015-2019)
  • Global Autoimmune Diseases Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Global Infectious Diseases Monoclonal Antibodies Market by Value (2015-2019)
  • Global Infectious Diseases Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Global Monoclonal Antibodies Market Value by End-Users (2019)
  • Global Hospital Monoclonal Antibodies Market by Value (2015-2019)
  • Global Hospital Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Global Research Institutes Monoclonal Antibodies Market by Value (2015-2019)
  • Global Research Institutes Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Global Monoclonal Antibodies Capacity and Demand Volume (2015-2024)
  • Global Monoclonal Antibodies Market Value by Region (2019)
  • North America Monoclonal Antibodies Market by Value (2015-2019)
  • North America Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • North America Monoclonal Antibodies Market by Region (2019)
  • The U.S. Monoclonal Antibodies Market by Value (2015-2019)
  • The U.S. Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • The U.S. Monoclonal Antibodies Market by Application (2019)
  • The U.S. Cancer Monoclonal Antibodies Market by Value (2015-2019)
  • The U.S. Cancer Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • The U.S. Autoimmune Diseases Monoclonal Antibodies Market by Value (2015-2019)
  • The U.S. Autoimmune Diseases Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • The U.S. Infectious Diseases Monoclonal Antibodies Market by Value (2015-2019)
  • The U.S. Infectious Diseases Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Europe Monoclonal Antibodies Market by Value (2015-2019)
  • Europe Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Asia Pacific Monoclonal Antibodies Market by Value (2015-2019)
  • Asia Pacific Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Latin America Monoclonal Antibodies Market by Value (2015-2019)
  • Latin America Monoclonal Antibodies Market Forecast by Value (2020-2024)
  • Middle East & Africa Monoclonal Antibodies Market by Value (2015-2019)
  • Middle East & Africa Antiviral Drugs Market Forecast by Value (2020-2024)
  • Global New Cases of Top Cancer Types (2019)
  • Global Biologics Market (2015-2019)
  • Global Geriatric Population - Age 65 and Above (2015-2019)
  • Global Pharmaceutical R&D Spending (2015-2019)
  • Global Diabetic Population by Top Countries (2019)
  • Global Healthcare Expenditure Per Capita (2015-2019)
  • Global Growth Rate of Infectious Diseases Forecast (2017-2022)
  • Global Pharmaceutical and Biotech M&A (2015-2019)
  • FDA-Approved Monoclonal Antibodies (2019)
  • Johnson & Johnson Total Sales and Net Earnings (2015-2019)
  • Johnson & Johnson Total Sales by Segments (2019)
  • Johnson & Johnson Total Sales by Regions (2019)
  • Novartis AG Net Sales and Net Income (2015-2019)
  • Novartis AG Net Sales by Segments (2019)
  • Novartis AG Net Sales by Regions (2019)
  • Merck and Co. Sales and Net Income (2015-2019)
  • Merck and Co. Sales by Segments (2019)
  • Merck and Co. Sales by Regions (2019)
  • AbbVie Inc. Net Revenue and Net Earnings (2015-2019)
  • AbbVie Inc. Net Revenue by Product (2019)
  • AbbVie Inc. Net Revenue by Regions (2019)
  • Bristol-Myers Squibb Total Revenue and Net Earnings (2015-2019)
  • Bristol-Myers Squibb Total Revenue by Operations (2019)
  • Bristol-Myers Squibb Total Revenue by Regions (2019)
  • Amgen AG Total Revenue and Net Income (2015-2019)
  • Amgen AG Total Revenue by Divisions (2019)
  • Amgen AG Total Revenue by Regions (2019)

List of Tables

  • Advantages and Disadvantages of Monoclonal Antibodies
  • Global COVID-19 Confirmed Deaths (2020)
  • COVID-19 Monoclonal Antibody Candidate Drugs in Phase III-IV Trials
  • Key Players - Revenue Comparison (2019)
  • Key Players - R&D Expenditure Comparison (2019)
  • Key Players - Market Capitalization Comparison (2020)